Global Cancer Biotherapy Market Research Report 2023

Cancer biotherapy is a form of treatment that uses the natural immune system to protect the body against cancer.

The global Cancer Biotherapy market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Cancer Biotherapy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Cancer Biotherapy is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Cancer Biotherapy in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Cancer Biotherapy include Amgen, Bristol-Myers Squibb, Celgene, GlaxoSmithKline and Eli Lilly, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Cancer Biotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Biotherapy.

The Cancer Biotherapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Cancer Biotherapy market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cancer Biotherapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cancer Biotherapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Monoclonal Antibodies

1.2.3 Vaccines

1.2.4 Erythropoietin

1.2.5 Colony Stimulating Factors

1.2.6 Interleukins and Interferons

1.3 Market by Application

1.3.1 Global Cancer Biotherapy Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Diagnostic Laboratories

1.3.4 Research and Academic Laboratories

1.3.5 Pharmaceutical and Biotechnology Companies

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Cancer Biotherapy Market Perspective (2018-2029)

2.2 Cancer Biotherapy Growth Trends by Region

2.2.1 Global Cancer Biotherapy Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Cancer Biotherapy Historic Market Size by Region (2018-2023)

2.2.3 Cancer Biotherapy Forecasted Market Size by Region (2024-2029)

2.3 Cancer Biotherapy Market Dynamics

2.3.1 Cancer Biotherapy Industry Trends

2.3.2 Cancer Biotherapy Market Drivers

2.3.3 Cancer Biotherapy Market Challenges

2.3.4 Cancer Biotherapy Market Restraints

3.1 Global Top Cancer Biotherapy Players by Revenue

3.1.1 Global Top Cancer Biotherapy Players by Revenue (2018-2023)

3.1.2 Global Cancer Biotherapy Revenue Market Share by Players (2018-2023)

3.2 Global Cancer Biotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Cancer Biotherapy Revenue

3.4 Global Cancer Biotherapy Market Concentration Ratio

3.4.1 Global Cancer Biotherapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cancer Biotherapy Revenue in 2022

3.5 Cancer Biotherapy Key Players Head office and Area Served

3.6 Key Players Cancer Biotherapy Product Solution and Service

3.7 Date of Enter into Cancer Biotherapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Cancer Biotherapy Historic Market Size by Type (2018-2023)

4.2 Global Cancer Biotherapy Forecasted Market Size by Type (2024-2029)

5.1 Global Cancer Biotherapy Historic Market Size by Application (2018-2023)

5.2 Global Cancer Biotherapy Forecasted Market Size by Application (2024-2029)

6.1 North America Cancer Biotherapy Market Size (2018-2029)

6.2 North America Cancer Biotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Cancer Biotherapy Market Size by Country (2018-2023)

6.4 North America Cancer Biotherapy Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Cancer Biotherapy Market Size (2018-2029)

7.2 Europe Cancer Biotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Cancer Biotherapy Market Size by Country (2018-2023)

7.4 Europe Cancer Biotherapy Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Cancer Biotherapy Market Size (2018-2029)

8.2 Asia-Pacific Cancer Biotherapy Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Cancer Biotherapy Market Size by Region (2018-2023)

8.4 Asia-Pacific Cancer Biotherapy Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Cancer Biotherapy Market Size (2018-2029)

9.2 Latin America Cancer Biotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Cancer Biotherapy Market Size by Country (2018-2023)

9.4 Latin America Cancer Biotherapy Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Cancer Biotherapy Market Size (2018-2029)

10.2 Middle East & Africa Cancer Biotherapy Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Cancer Biotherapy Market Size by Country (2018-2023)

10.4 Middle East & Africa Cancer Biotherapy Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Amgen

11.1.1 Amgen Company Detail

11.1.2 Amgen Business Overview

11.1.3 Amgen Cancer Biotherapy Introduction

11.1.4 Amgen Revenue in Cancer Biotherapy Business (2018-2023)

11.1.5 Amgen Recent Development

11.2 Bristol-Myers Squibb

11.2.1 Bristol-Myers Squibb Company Detail

11.2.2 Bristol-Myers Squibb Business Overview

11.2.3 Bristol-Myers Squibb Cancer Biotherapy Introduction

11.2.4 Bristol-Myers Squibb Revenue in Cancer Biotherapy Business (2018-2023)

11.2.5 Bristol-Myers Squibb Recent Development

11.3 Celgene

11.3.1 Celgene Company Detail

11.3.2 Celgene Business Overview

11.3.3 Celgene Cancer Biotherapy Introduction

11.3.4 Celgene Revenue in Cancer Biotherapy Business (2018-2023)

11.3.5 Celgene Recent Development

11.4 GlaxoSmithKline

11.4.1 GlaxoSmithKline Company Detail

11.4.2 GlaxoSmithKline Business Overview

11.4.3 GlaxoSmithKline Cancer Biotherapy Introduction

11.4.4 GlaxoSmithKline Revenue in Cancer Biotherapy Business (2018-2023)

11.4.5 GlaxoSmithKline Recent Development

11.5 Eli Lilly

11.5.1 Eli Lilly Company Detail

11.5.2 Eli Lilly Business Overview

11.5.3 Eli Lilly Cancer Biotherapy Introduction

11.5.4 Eli Lilly Revenue in Cancer Biotherapy Business (2018-2023)

11.5.5 Eli Lilly Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Cancer Biotherapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Monoclonal Antibodies

    Table 3. Key Players of Vaccines

    Table 4. Key Players of Erythropoietin

    Table 5. Key Players of Colony Stimulating Factors

    Table 6. Key Players of Interleukins and Interferons

    Table 7. Global Cancer Biotherapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Cancer Biotherapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 9. Global Cancer Biotherapy Market Size by Region (2018-2023) & (US$ Million)

    Table 10. Global Cancer Biotherapy Market Share by Region (2018-2023)

    Table 11. Global Cancer Biotherapy Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 12. Global Cancer Biotherapy Market Share by Region (2024-2029)

    Table 13. Cancer Biotherapy Market Trends

    Table 14. Cancer Biotherapy Market Drivers

    Table 15. Cancer Biotherapy Market Challenges

    Table 16. Cancer Biotherapy Market Restraints

    Table 17. Global Cancer Biotherapy Revenue by Players (2018-2023) & (US$ Million)

    Table 18. Global Cancer Biotherapy Market Share by Players (2018-2023)

    Table 19. Global Top Cancer Biotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biotherapy as of 2022)

    Table 20. Ranking of Global Top Cancer Biotherapy Companies by Revenue (US$ Million) in 2022

    Table 21. Global 5 Largest Players Market Share by Cancer Biotherapy Revenue (CR5 and HHI) & (2018-2023)

    Table 22. Key Players Headquarters and Area Served

    Table 23. Key Players Cancer Biotherapy Product Solution and Service

    Table 24. Date of Enter into Cancer Biotherapy Market

    Table 25. Mergers & Acquisitions, Expansion Plans

    Table 26. Global Cancer Biotherapy Market Size by Type (2018-2023) & (US$ Million)

    Table 27. Global Cancer Biotherapy Revenue Market Share by Type (2018-2023)

    Table 28. Global Cancer Biotherapy Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 29. Global Cancer Biotherapy Revenue Market Share by Type (2024-2029)

    Table 30. Global Cancer Biotherapy Market Size by Application (2018-2023) & (US$ Million)

    Table 31. Global Cancer Biotherapy Revenue Market Share by Application (2018-2023)

    Table 32. Global Cancer Biotherapy Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 33. Global Cancer Biotherapy Revenue Market Share by Application (2024-2029)

    Table 34. North America Cancer Biotherapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. North America Cancer Biotherapy Market Size by Country (2018-2023) & (US$ Million)

    Table 36. North America Cancer Biotherapy Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Europe Cancer Biotherapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Europe Cancer Biotherapy Market Size by Country (2018-2023) & (US$ Million)

    Table 39. Europe Cancer Biotherapy Market Size by Country (2024-2029) & (US$ Million)

    Table 40. Asia-Pacific Cancer Biotherapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Asia-Pacific Cancer Biotherapy Market Size by Region (2018-2023) & (US$ Million)

    Table 42. Asia-Pacific Cancer Biotherapy Market Size by Region (2024-2029) & (US$ Million)

    Table 43. Latin America Cancer Biotherapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Latin America Cancer Biotherapy Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Latin America Cancer Biotherapy Market Size by Country (2024-2029) & (US$ Million)

    Table 46. Middle East & Africa Cancer Biotherapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 47. Middle East & Africa Cancer Biotherapy Market Size by Country (2018-2023) & (US$ Million)

    Table 48. Middle East & Africa Cancer Biotherapy Market Size by Country (2024-2029) & (US$ Million)

    Table 49. Amgen Company Detail

    Table 50. Amgen Business Overview

    Table 51. Amgen Cancer Biotherapy Product

    Table 52. Amgen Revenue in Cancer Biotherapy Business (2018-2023) & (US$ Million)

    Table 53. Amgen Recent Development

    Table 54. Bristol-Myers Squibb Company Detail

    Table 55. Bristol-Myers Squibb Business Overview

    Table 56. Bristol-Myers Squibb Cancer Biotherapy Product

    Table 57. Bristol-Myers Squibb Revenue in Cancer Biotherapy Business (2018-2023) & (US$ Million)

    Table 58. Bristol-Myers Squibb Recent Development

    Table 59. Celgene Company Detail

    Table 60. Celgene Business Overview

    Table 61. Celgene Cancer Biotherapy Product

    Table 62. Celgene Revenue in Cancer Biotherapy Business (2018-2023) & (US$ Million)

    Table 63. Celgene Recent Development

    Table 64. GlaxoSmithKline Company Detail

    Table 65. GlaxoSmithKline Business Overview

    Table 66. GlaxoSmithKline Cancer Biotherapy Product

    Table 67. GlaxoSmithKline Revenue in Cancer Biotherapy Business (2018-2023) & (US$ Million)

    Table 68. GlaxoSmithKline Recent Development

    Table 69. Eli Lilly Company Detail

    Table 70. Eli Lilly Business Overview

    Table 71. Eli Lilly Cancer Biotherapy Product

    Table 72. Eli Lilly Revenue in Cancer Biotherapy Business (2018-2023) & (US$ Million)

    Table 73. Eli Lilly Recent Development

    Table 74. Research Programs/Design for This Report

    Table 75. Key Data Information from Secondary Sources

    Table 76. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Cancer Biotherapy Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Cancer Biotherapy Market Share by Type: 2022 VS 2029

    Figure 3. Monoclonal Antibodies Features

    Figure 4. Vaccines Features

    Figure 5. Erythropoietin Features

    Figure 6. Colony Stimulating Factors Features

    Figure 7. Interleukins and Interferons Features

    Figure 8. Global Cancer Biotherapy Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 9. Global Cancer Biotherapy Market Share by Application: 2022 VS 2029

    Figure 10. Hospitals Case Studies

    Figure 11. Diagnostic Laboratories Case Studies

    Figure 12. Research and Academic Laboratories Case Studies

    Figure 13. Pharmaceutical and Biotechnology Companies Case Studies

    Figure 14. Others Case Studies

    Figure 15. Cancer Biotherapy Report Years Considered

    Figure 16. Global Cancer Biotherapy Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 17. Global Cancer Biotherapy Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 18. Global Cancer Biotherapy Market Share by Region: 2022 VS 2029

    Figure 19. Global Cancer Biotherapy Market Share by Players in 2022

    Figure 20. Global Top Cancer Biotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biotherapy as of 2022)

    Figure 21. The Top 10 and 5 Players Market Share by Cancer Biotherapy Revenue in 2022

    Figure 22. North America Cancer Biotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. North America Cancer Biotherapy Market Share by Country (2018-2029)

    Figure 24. United States Cancer Biotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Canada Cancer Biotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. Europe Cancer Biotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. Europe Cancer Biotherapy Market Share by Country (2018-2029)

    Figure 28. Germany Cancer Biotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. France Cancer Biotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. U.K. Cancer Biotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Italy Cancer Biotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Russia Cancer Biotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Nordic Countries Cancer Biotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Asia-Pacific Cancer Biotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Asia-Pacific Cancer Biotherapy Market Share by Region (2018-2029)

    Figure 36. China Cancer Biotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Japan Cancer Biotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. South Korea Cancer Biotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Southeast Asia Cancer Biotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. India Cancer Biotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Australia Cancer Biotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Latin America Cancer Biotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Latin America Cancer Biotherapy Market Share by Country (2018-2029)

    Figure 44. Mexico Cancer Biotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Brazil Cancer Biotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Middle East & Africa Cancer Biotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Middle East & Africa Cancer Biotherapy Market Share by Country (2018-2029)

    Figure 48. Turkey Cancer Biotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 49. Saudi Arabia Cancer Biotherapy Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 50. Amgen Revenue Growth Rate in Cancer Biotherapy Business (2018-2023)

    Figure 51. Bristol-Myers Squibb Revenue Growth Rate in Cancer Biotherapy Business (2018-2023)

    Figure 52. Celgene Revenue Growth Rate in Cancer Biotherapy Business (2018-2023)

    Figure 53. GlaxoSmithKline Revenue Growth Rate in Cancer Biotherapy Business (2018-2023)

    Figure 54. Eli Lilly Revenue Growth Rate in Cancer Biotherapy Business (2018-2023)

    Figure 55. Bottom-up and Top-down Approaches for This Report

    Figure 56. Data Triangulation

    Figure 57. Key Executives Interviewed